Home NDC 62032-528 Obagi Medical - Nu-Derm System - Normal to Dry - Skin Transformation Trial Kit
Product NDC 62032-528
11-digit product format 620320528
Labeler code 62032
Product ID 62032-528_77acc881-f597-4799-873e-2505a8f6c64a
Type HUMAN OTC DRUG
Nonproprietary name Octinoxate, Zinc Oxide
Dosage form KIT
Labeler Obagi Cosmeceuticals LLC
Marketing category UNAPPROVED DRUG OTHER
Marketing start 2015-11-16
Marketing end 0000-00-00
Active strength 0
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 30 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 62032-528-07 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 62032-528-07 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 62032-528-07 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 62032-528-07 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 62032-528-07 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 62032-528-07 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 62032-528-07 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 62032-528-07 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 62032-528-07 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 62032-528-07 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 62032-528-07 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 62032-528-07 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 62032-528-07 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 62032-528-07 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 62032-528-07 1332a3947898…d4bfe170f9cd…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 62032-528-07 Obagi Medical - Nu-Derm System - Normal to Dry - Skin Transformation Trial Kit 1 in 1 CARTON KIT 1 2
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded HYDROQUINONE ACTIVE INGREDIENT XV74C1N1AE OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 OCTINOXATE ACTIVE INGREDIENT 4Y5P7MUD51 OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 ZINC OXIDE ACTIVE INGREDIENT SOI2LOH54Z OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 HYDROQUINONE ACTIVE MOIETY XV74C1N1AE OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 OCTINOXATE ACTIVE MOIETY 4Y5P7MUD51 OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 ZINC OXIDE ACTIVE MOIETY SOI2LOH54Z OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 .ALPHA.-TOCOPHEROL ACETATE INACTIVE INGREDIENT 9E8X80D2L0 OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 1,2-HEXANEDIOL INACTIVE INGREDIENT TR046Y3K1G OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 ASCORBIC ACID INACTIVE INGREDIENT PQ6CK8PD0R OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 BUTYLATED HYDROXYTOLUENE INACTIVE INGREDIENT 1P9D0Z171K OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 BUTYLPARABEN INACTIVE INGREDIENT 3QPI1U3FV8 OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 CAPRYLYL GLYCOL INACTIVE INGREDIENT 00YIU5438U OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 CETOSTEARYL ALCOHOL INACTIVE INGREDIENT 2DMT128M1S OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 CETYL ALCOHOL INACTIVE INGREDIENT 936JST6JCN OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 CHLORPHENESIN INACTIVE INGREDIENT I670DAL4SZ OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 CITRIC ACID MONOHYDRATE INACTIVE INGREDIENT 2968PHW8QP OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 CYCLOMETHICONE 5 INACTIVE INGREDIENT 0THT5PCI0R OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 DIMETHICONE INACTIVE INGREDIENT 92RU3N3Y1O OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 EDETATE DISODIUM INACTIVE INGREDIENT 7FLD91C86K OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 HYDROGENATED PALM GLYCERIDES INACTIVE INGREDIENT YCZ8EM144Q OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%) INACTIVE INGREDIENT 86FQE96TZ4 OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 LACTIC ACID INACTIVE INGREDIENT 33X04XA5AT OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 METHYLISOTHIAZOLINONE INACTIVE INGREDIENT 229D0E1QFA OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 PEG-40 STEARATE INACTIVE INGREDIENT ECU18C66Q7 OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 PENTYLENE GLYCOL INACTIVE INGREDIENT 50C1307PZG OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 PHENOXYETHANOL INACTIVE INGREDIENT HIE492ZZ3T OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 PHENYL TRIMETHICONE INACTIVE INGREDIENT DR0K5NOJ4R OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 POLYOXYL 20 CETOSTEARYL ETHER INACTIVE INGREDIENT YRC528SWUY OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 POLYSORBATE 60 INACTIVE INGREDIENT CAL22UVI4M OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 POTASSIUM SORBATE INACTIVE INGREDIENT 1VPU26JZZ4 OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 PPG-2 MYRISTYL ETHER PROPIONATE INACTIVE INGREDIENT 88R97D8U8A OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 PROPYLPARABEN INACTIVE INGREDIENT Z8IX2SC1OH OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 SODIUM BENZOATE INACTIVE INGREDIENT OJ245FE5EU OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 SODIUM DIHYDROXYCETYL PHOSPHATE INACTIVE INGREDIENT YWI33EV595 OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 SODIUM METABISULFITE INACTIVE INGREDIENT 4VON5FNS3C OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 SQUALANE INACTIVE INGREDIENT GW89575KF9 OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 STEARYL ALCOHOL INACTIVE INGREDIENT 2KR89I4H1Y OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 TETRAHEXYLDECYL ASCORBATE INACTIVE INGREDIENT 9LBV3F07AZ OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 TROLAMINE SALICYLATE INACTIVE INGREDIENT H8O4040BHD OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 TROPOLONE INACTIVE INGREDIENT 7L6DL16P1T OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 WATER INACTIVE INGREDIENT 059QF0KO0R OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1 XANTHAN GUM INACTIVE INGREDIENT TTV12P4NEE OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OMP, INC.] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 62032-528 OBAGI MEDICAL - NU-DERM SYSTEM - NORMAL TO DRY - SKIN TRANSFORMATION TRIAL KIT (OCTINOXATE, ZINC OXIDE) KIT [OBAGI COSMECEUTICALS LLC] 2 Legacy NDC, 1 package rows 20191115_2b445250-ab56-4ed1-9ea3-186817d47090.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 62032-528-07 62032052807 1 KIT in 1 CARTON (62032-528-07) * 57 g in 1 BOTTLE, PLASTIC * 28 g in 1 BOTTLE, PLASTIC * 28 g in 1 TUBE 1 kit 2015-11-16 0000-00-00 No No Current